Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone in MCI and OSA
NCT05209035Phase 4Active, not recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trazodone in Mild Cognitive Impairment (MCI), obstructive sleep apnea (OSA), sponsored by The Chinese University of Hong Kong. Started May 2022; status: active, not recruiting.
02
Drugs
trazodone
03
Conditions
Mild Cognitive Impairment (MCI)obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05209035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05209035.